#BEGIN_DRUGCARD DB04265

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C11H19NO9

# Chemical_IUPAC_Name:
(2S,4R,5S,6S)-5-acetamido-2,4-dihydroxy-6-[(1S,2S)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
An N-acyl derivative of neuraminic acid. N-acetylneuraminic acid occurs in many polysaccharides, glycoproteins, and glycolipids in animals and bacteria. (From Dorland, 28th ed, p1518)

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Beta-Sialic Acid

# HET_ID:
SLB

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C11H19NO9/c1-4(14)12-7-5(15)2-11(20,10(18)19)21-9(7)8(17)6(16)3-13/h5-9,13,15-17,20H,2-3H2,1H3,(H,12,14)(H,18,19)/t5-,6+,7+,8+,9+,11+/m1/s1

# InChI_Key:
InChIKey=SQVRNKJHWKZAKO-LLYCPFJPSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4265

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
309.2699

# Molecular_Weight_Mono:
309.105981211

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
2BER

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.8

# Predicted_LogS:
-0.13

# Predicted_Water_Solubility:
2.27e+02 g/l

# Primary_Accession_No:
DB04265

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
36690637

# PubChem_Substance_ID:
46508038

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02915

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC(=O)N[C@H]1[C@H](O)C[C@](O)(O[C@@H]1[C@@H](O)[C@@H](O)CO)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:09 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Secreted protein

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
D01045

# Drug_Target_1_GenBank_ID_Protein:
216784

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
nedA

# Drug_Target_1_Gene_Sequence:
>1944 bp
ATGACTGCGAATCCGTACCTCCGCCGCCTGCCCCGGCGCCGAGCCGTCAGCTTCCTGCTC
GCACCAGCGCTGGCGGCCGCCACGGTCGCCGGCGCGTCCCCCGCACAGGCCATCGCCGGG
GCACCCGTCCCGCCCGGCGGCGAGCCGCTCTACACGGAGCAGGACCTCGCCGTGAACGGC
AGGGAGGGCTTTCCGAACTACCGCATCCCAGCGCTGACCGTCACGCCCGACGGGGACCTG
CTGGCCTCGTACGACGGCCGCCCGACCGGTATCGACGCGCCCGGCCCCAACTCCATCCTC
CAACGCCGCAGCACCGACGGCGGCCGGACGTGGGGCGAGCAACAGGTCGTCAGCGCCGGC
CAGACCACCGCGCCGATCAAGGGGTTCTCCGACCCCAGCTACCTTGTCGACCGGGAAACC
GGGACCATCTTCAACTTCCACGTCTACTCCCAGCGGCAGGGCTTCGCCGGCAGCCGGCCC
GGCACCGACCCGGCAGACCCCAACGTGCTCCACGCCAACGTCGCGACCTCGACCGACGGC
GGTCTGACCTGGTCGCACCGGACCATCACGGCCGACATCACCCCGGATCCGGGCTGGCGC
AGCCGCTTCGCCGCCTCCGGCGAAGGCATCCAGCTCCGCTATGGACCCCACGCCGGTCGA
CTCATCCAGCAGTACACGATCATCAACGCTGCCGGCGCCTTCCAGGCGGTGAGCGTGTAC
AGCGACGACCACGGAAGGACCTGGCGCGCCGGCGAAGCCGTCGGGGTCGGCATGGACGAG
AACAAGACCGTGGAACTCTCCGATGGCCGGGTCCTGCTCAACAGCCGCGACTCGGCCCGC
AGCGGATACCGTAAGGTGGCCGTCTCCACTGACGGCGGCCACAGCTACGGCCCGGTGACC
ATCGACCGCGACCTCCCCGACCCGACGAACAACGCATCGATCATCCGGGCCTTCCCTGAC
GCCCCGGCCGGCTCCGCGCGGGCCAAGGTCCTGCTCTTCTCCAACGCCGCCAGCCAGACC
TCGCGCAGTCAGGGCACCATCCGGATGTCCTGCGACGATGGCCAGACCTGGCCGGTTTCG
AAGGTCTTCCAGCCCGGCTCGATGTCGTACTCCACCCTGACCGCACTGCCCGACGGCACC
TACGGGCTGCTGTACGAGCCGGGCACCGGCATCAGATACGCCAACTTCAACCTCGCCTGG
CTGGGCGGCATCTGCGCGCCCTTCACGATTCCGGATGTGGCGCTCGAGCCGGGCCAGCAG
GTCACTGTTCCGGTGGCCGTCACGAACCAGTCCGGTATCGCGGTACCGAAGCCGAGCCTT
CAGCTCGACGCATCGCCGGACTGGCAGGTTCAGGGTTCCGTCGAGCCCCTCATGCCCGGA
CGGCAGGCCAAGGGCCAGGTGACCATCACGGTTCCCGCCGGCACCACCCCCGGTCGCTAC
CGGGTCGGTGCGACGCTGCGCACCTCCGCGGGTAACGCGTCGACGACCTTCACGGTCACG
GTTGGACTGCTCGACCAGGCCCGGATGAGCATCGCGGACGTCGACAGCGAGGAGACCGCC
CGCGAAGACGGGCGGGCGAGCAACGTGATCGACGGCAACCCCTCGACGTTCTGGCACACC
GAATGGTCGCGTGCCGATGCTCCTGGCTACCCGCACCGCATCAGCCTCGACCTCGGTGGC
ACGCACACGATCAGCGGCCTCCAGTACACCCGACGGCAGAACAGCGCCAACGAGCAGGTC
GCGGACTACGAGATCTACACCAGCCTGAACGGCACGACCTGGGATGGCCCGGTTGCCAGC
GGGCGCTTCACCACGTCCCTCGCGCCGCAGCGCGCGGTCTTCCCGGCGCGGGACGCCAGG
TACATCCGGTTGGTGGCCCTCAGCGAGCAGACCGGGCACAAGTACGCCGCGGTCGCTGAG
CTGGAGGTGGAAGGCCAGCGCTGA

# Drug_Target_1_General_Function:
Involved in exo-alpha-sialidase activity

# Drug_Target_1_General_References:
1400240	Sakurada K, Ohta T, Hasegawa M: Cloning, expression, and characterization of the Micromonospora viridifaciens neuraminidase gene in Streptomyces lividans. J Bacteriol. 1992 Nov;174(21):6896-903.
8591030	Gaskell A, Crennell S, Taylor G: The three domains of a bacterial sialidase: a beta-propeller, an immunoglobulin module and a galactose-binding jelly-roll. Structure. 1995 Nov 15;3(11):1197-205.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3546

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
68831

# Drug_Target_1_Name:
Sialidase

# Drug_Target_1_Number_of_Residues:
647

# Drug_Target_1_PDB_ID:
1EUU

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00754	F5_F8_type_C
PF02012	BNR

# Drug_Target_1_Protein_Sequence:
>Sialidase precursor
MTANPYLRRLPRRRAVSFLLAPALAAATVAGASPAQAIAGAPVPPGGEPLYTEQDLAVNG
REGFPNYRIPALTVTPDGDLLASYDGRPTGIDAPGPNSILQRRSTDGGRTWGEQQVVSAG
QTTAPIKGFSDPSYLVDRETGTIFNFHVYSQRQGFAGSRPGTDPADPNVLHANVATSTDG
GLTWSHRTITADITPDPGWRSRFAASGEGIQLRYGPHAGRLIQQYTIINAAGAFQAVSVY
SDDHGRTWRAGEAVGVGMDENKTVELSDGRVLLNSRDSARSGYRKVAVSTDGGHSYGPVT
IDRDLPDPTNNASIIRAFPDAPAGSARAKVLLFSNAASQTSRSQGTIRMSCDDGQTWPVS
KVFQPGSMSYSTLTALPDGTYGLLYEPGTGIRYANFNLAWLGGICAPFTIPDVALEPGQQ
VTVPVAVTNQSGIAVPKPSLQLDASPDWQVQGSVEPLMPGRQAKGQVTITVPAGTTPGRY
RVGATLRTSAGNASTTFTVTVGLLDQARMSIADVDSEETAREDGRASNVIDGNPSTFWHT
EWSRADAPGYPHRISLDLGGTHTISGLQYTRRQNSANEQVADYEIYTSLNGTTWDGPVAS
GRFTTSLAPQRAVFPARDARYIRLVALSEQTGHKYAAVAELEVEGQR

# Drug_Target_1_Reaction:
Hydrolysis of alpha-(2->3)-, alpha-(2->6)-, alpha-(2->8)- glycosidic linkages of terminal sialic acid residues in oligosaccharides, glycoproteins, glycolipids, colominic acid and synthetic substrates ALL_REAC (other) R03491 R04018 R04634 R04650 R05115 R05117 R05996(G) R05998(G) R05999(G) R06012(G) R06147(G) R06253(G) INHIBITOR 2-Deoxy-2,3-dehydro-N-acetylneuraminic acid

# Drug_Target_1_Signals:
1-37

# Drug_Target_1_Specific_Function:
To release sialic acids for use as carbon and energy sources for this non-pathogenic bacterium while in pathogenic microorganisms, sialidases have been suggested to be pathogenic factors

# Drug_Target_1_SwissProt_ID:
Q02834

# Drug_Target_1_SwissProt_Name:
NANH_MICVI

# Drug_Target_1_Synonyms:
EC 3.2.1.18
Neuraminidase
Sialidase precursor

# Drug_Target_1_Theoretical_pI:
6.52

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
Not Available

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
Not Available

# Drug_Target_2_Gene_Sequence:
>2763 bp
ATGTCCACGATTACACAATTCCCTTCAGGAAACACTCAGTACAGGATTGAGTTCGACTAC
CTAGCCAGAACGTTTGTTGTTGTTACGCTGGTGAATAGCTCTAACCCTACCCTGAACCGT
GTACTGGAAGTTGGTCGAGATTACCGATTCCTTAACCCAACGATGATTGAGATGTTGGTG
GACCAATCAGGTTTCGACATCGTTCGTATTCACCGTCAGACTGGGACTGACTTAGTGGTA
GACTTCAGGAATGGCTCAGTGTTGACAGCTAGTGACCTGACCACTGCAGAGCTTCAGGCT
ATCCATATTGCAGAAGAAGGTCGAGACCAAACGGTTGACTTAGCGAAGGAATATGCCGAT
GCTGCTGGTAGCTCTGCTGGCAACGCTAAGGATAGCGAGGACGAAGCACGACGAATCGCT
GAGAGTATCAGGGCAGCTGGTCTAATTGGTTATATGACCCGTCGCTCCTTCGAGAAAGGC
TACAACGTTACAACATGGAGCGAGGTCCTGCTATGGGAAGAGGATGGTGATTATTACCGC
TGGGATGGTACGCTTCCAAAGAACGTTCCTGCTGGTTCAACTCCTGAAACTTCCGGTGGG
ATTGGATTAGGTGCGTGGGTTAGTGTTGGTGATGCTGCTTTAAGAAGTCAGATTTCAAAC
CCGGAAGGGGCAATACTCTACCCTGAATTACATAGAGCACGCTGGCTTGATGAAAAAGAT
GCTCGTGGTTGGGGTGCTAAAGGGGATGGTGTCACTGATGATACAGCAGCGTTAACGAGC
GCATTAAACGACACACCGGTTGGACAAAAGATTAATGGCAATGGGAAGACATATAAGGTC
ACATCCCTGCCTGACATTAGTCGCTTCATCAACACTCGTTTCGTTTATGAGCGCATTCCC
GGACAACCTCTTTATTATGCCTCTGAAGAATTTGTTCAGGGTGAGCTATTCAAAATAACG
GACACCCCTTATTACAATGCGTGGCCTCAGGATAAAGCGTTCGTATATGAGAATGTGATA
TATGCACCTTACATGGGTAGCGATCGTCATGGTGTTAGTCGTCTGCATGTATCATGGGTT
AAGTCTGGTGATGATGGTCAAACATGGTCTACTCCAGAGTGGTTAACTGATCTGCATCCA
GATTACCCTACAGTGAACTATCATTGTATGAGTATGGGTGTATGTCGCAACCGTCTGTTT
GCCATGATTGAAACACGTACCTTAGCCAAGAACGCATTAACCAATTGTGCATTGTGGGAT
CGCCCCATGTCTCGTAGCCTGCATCTTACTGGTGGTATCACTAAAGCTGCAAATCAGCGA
TATGCAACAATACATGTACCAGACCACGGACTATTCGTGGGTGATTTTGTTAACTTCTCT
AATTCTGCGGTAACAGGTGTATCCGGTGATATGACTGTTGCAACCGTAATAGATAAGGAC
AACTTCACGGTTCTTACACCCAACCAGCAGACTTCAGATTTGAATAACGCTGGAAAGAAT
TGGCACATGGGTACTTCTTTCCATAAGTCTCCATGGCGTAAGACAGATCTTGGTCTAATC
CCTAGTGTCACAGAGGTGCATAGCTTTGCTACTATTGATAACAATGGCTTTGCTATGGGC
TATCATCAAGGTGATGTAGCTCCACGAGAAGTTGGGCTTTTCTACTTCCCTGATGCTTTC
AATAGCCCATCTAATTATGTTCGTCGTCAGATACCATCTGAGTATGAACCAGATGCGTCA
GAGCCGTGCATCAAGTACTATGACGGTGTATTATACCTTATCACTCGTGGCACTCGTGGT
GATAGACTAGGTAGCTCTTTGCATCGTAGTAGAGACATAGGTCAGACTTGGGAGTCACTG
AGATTTCCACATAATGTTCATCGTACTACATTACCTTTTGCTAAAGTAGGGGATGACCTT
ATTATGTTTGGTTCAGAACGTGCAGAAAATGAATGGGAAGCAGGTGCACCAGATGATCGT
TACAAGGCATCTTATCCTCGCACCTTCTATGCACGCTTGAATGTAAACAATTGGAATGCA
GATGATATTGAATGGGTTAACATCACTGACCAGATTTATCAGGGCGGAATAGTTAACTCA
GGTGTAGGTGTTGGTTCGGTAGTTGTGAAGGATAATTACATCTACTACATGTTTGGTGGA
GAGGACCATTTTAACCCATGGACATATGGAGATAACTCAGCGAAAGACCCATTCAAATCG
GATGGTCACCCCTCGGATTTGTATTGCTACAAAATGAAGATTGGCCCAGACAATCGTGTT
TCCAGAGATTTCAGATATGGTGCTGTACCCAACAGAGCTGTTCCCGTGTTTTTTGATACG
AATGGGGTTCGCACTGTTCCTGCGCCAATGGAATTTACAGGGGATTTGGGTTTAGGTCAT
GTGACCATTAGAGCCAGCACCAGTAGTAACATTCGCTCTGAAGTTTTAATGGAAGGTGAA
TATGGGTTTATCGGGAAATCTATACCGACTGATAACCCGGCAGGGCAGCGCATCATATTT
TGCGGGGGTGAAGGCACCAGTTCAACGACTGGCGCACAGATTACGCTATATGGTGCAAAT
AACACCGACTCAAGGCGAATAGTTTACAACGGAGATGAGCATCTATTTCAGAGTGCTGAT
GTTAAGCCTTATAACGATAACGTCACTGCGCTTGGTGGGCCTAGCAACCGTTTCACCACT
GCATACCTCGGAAGCAACCCTATTGTTACTTCTAACGGGGGAGGAGGAAAACAGAGCCGG
TAG

# Drug_Target_2_General_Function:
Involved in endo-alpha-sialidase activity

# Drug_Target_2_General_References:
8331067	Petter JG, Vimr ER: Complete nucleotide sequence of the bacteriophage K1F tail gene encoding endo-N-acylneuraminidase (endo-N) and comparison to an endo-N homolog in bacteriophage PK1E. J Bacteriol. 1993 Jul;175(14):4354-63.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
3629

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
102014

# Drug_Target_2_Name:
Endo-N-acetylneuraminidase

# Drug_Target_2_Number_of_Residues:
920

# Drug_Target_2_PDB_ID:
1V0F

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF02012	BNR
PF03906	Phage_T7_tail

# Drug_Target_2_Protein_Sequence:
>Endo-N-acetylneuraminidase
MSTITQFPSGNTQYRIEFDYLARTFVVVTLVNSSNPTLNRVLEVGRDYRFLNPTMIEMLV
DQSGFDIVRIHRQTGTDLVVDFRNGSVLTASDLTTAELQAIHIAEEGRDQTVDLAKEYAD
AAGSSAGNAKDSEDEARRIAESIRAAGLIGYMTRRSFEKGYNVTTWSEVLLWEEDGDYYR
WDGTLPKNVPAGSTPETSGGIGLGAWVSVGDAALRSQISNPEGAILYPELHRARWLDEKD
ARGWGAKGDGVTDDTAALTSALNDTPVGQKINGNGKTYKVTSLPDISRFINTRFVYERIP
GQPLYYASEEFVQGELFKITDTPYYNAWPQDKAFVYENVIYAPYMGSDRHGVSRLHVSWV
KSGDDGQTWSTPEWLTDLHPDYPTVNYHCMSMGVCRNRLFAMIETRTLAKNALTNCALWD
RPMSRSLHLTGGITKAANQRYATIHVPDHGLFVGDFVNFSNSAVTGVSGDMTVATVIDKD
NFTVLTPNQQTSDLNNAGKNWHMGTSFHKSPWRKTDLGLIPSVTEVHSFATIDNNGFAMG
YHQGDVAPREVGLFYFPDAFNSPSNYVRRQIPSEYEPDASEPCIKYYDGVLYLITRGTRG
DRLGSSLHRSRDIGQTWESLRFPHNVHRTTLPFAKVGDDLIMFGSERAENEWEAGAPDDR
YKASYPRTFYARLNVNNWNADDIEWVNITDQIYQGGIVNSGVGVGSVVVKDNYIYYMFGG
EDHFNPWTYGDNSAKDPFKSDGHPSDLYCYKMKIGPDNRVSRDFRYGAVPNRAVPVFFDT
NGVRTVPAPMEFTGDLGLGHVTIRASTSSNIRSEVLMEGEYGFIGKSIPTDNPAGQRIIF
CGGEGTSSTTGAQITLYGANNTDSRRIVYNGDEHLFQSADVKPYNDNVTALGGPSNRFTT
AYLGSNPIVTSNGGGGKQSR

# Drug_Target_2_Reaction:
Endohydrolysis of (2->8)-alpha-sialosyl linkages in oligo- or poly(sialic) acids

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Responsible for initial absorption of the phage to the host bacterium. Degradation of the alpha-2,8-linked polysialic acid K1 capsule

# Drug_Target_2_SwissProt_ID:
Q04830

# Drug_Target_2_SwissProt_Name:
ENAN_BPK1F

# Drug_Target_2_Synonyms:
EC 3.2.1.129
Endo-N
Endosialidase
G102

# Drug_Target_2_Theoretical_pI:
5.37

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Membrane
single-pass type II membrane protein

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
M18764

# Drug_Target_3_GenBank_ID_Protein:
332715

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
HN

# Drug_Target_3_Gene_Sequence:
>1719 bp
ATGGAATACTGGAAGCATACCAATCACGGAAAGGATGCTGGTAATGAGCTGGAGACGTCC
ATGGCTACTCATGGCAACAAGCTCACTAATAAGATAATATACATATTATGGACAATAATC
CTGGTGTTATTATCAATAGTCTTCATCATAGTGCTAATCAATTCCATCAAAAGTGAAAAG
GCCCACGAATCATTGCTGCGAGACATAAACAATGAGTTTATGGAAATTACAGGAAAGATC
CAAATGGCATCGGATAATACCAATGATCTAATACAGTCAGGAGTGAATACAAGGCTTCTT
ACAATTCAGAGTCATGTCCAGAATTACATACCAATATCATTGACACAACAGATGTCAGAT
CTTAGGAAATTCATTAGTGAAATTACAATTAGAAATGATAATCAAGAAGTGCTGCCGCAA
AGAATAACACATGATGTAGGTATAAAACCTTTAAATCCAGATGATTTTTGGAGATGCACG
TCTGGTCTTCCATCTTTAATGAAAACTCCAAAAATAAGGTTAATGCCAGGGCCGGGGTTA
TTAGCTATGCCAACGACTGATGATGGCTGTATTAGAACTCCGTCTTTAGTTATAAATGAT
CTGATTTATGCTTATACCTCAAATCTAATTACTCGAGGTTGTCAGGATATAGGAAAATCA
TATCAAGTCTTACAGATAGGGATAATAACTGTAAACTCAGACTTGGTACCTGACTTAAAT
CCTAGGATCTCTCATACTTTCAACATAAATGACAATAGGAAGTCATGCTCTCTAGCACTC
CTAAATACAGATGTATATCAACTGTGTTCAACTCCCAAAGTTGATGAAAGATCAGATTAT
GCATCATCAGGCATAGAAGATATTGTACTTGATATTGTCAATTATGATGGCTCAATCTCA
ACAACAAGATTTAAGAATAATAACATAAGCTTTGATCAACCATATGCTGCGCTATACCCA
TCTGTTGGACCAGGGATATACTACAAAGGCAAAATAATATTTCTCGGATATGGAGGTCTT
GAACATCCAATAAATGAGAATGTAATCTGCAATACAACTGGGTGTCCCGGGAAAACACAG
AGAGACTGTAATCAAGCGTCTCATAGTCCATGGTTTTCAGATAGGAGGATGGTCAACTCC
ATCATTGTTGTTGACAAAGGCTTAAACTCAACTCCAAAATTGAAGGTATGGACGATATCT
ATGCGACAAAATTACTGGGGGTCAGAAGGAAGGTTACTTCTACTAGGTAACAAGATCTAT
ATATATACAAGATCTACAAGTTGGCATAGCAAGTTACAATTAGGAATAATTGATATTACT
GATTACAGTGATATAAGGATAAAATGGACATGGCATAATGTGCTATCAAGACCAGGAAAC
AATGAATGTCCATGGGGACATTCATGTCCAGATGGATGTATAACAGGAGTATATACTGAT
GCATATCCACTCAATCCCACAGGGAGCATTGTGTCATCTGTCATATTAGACTCACAAAAA
TCGAGAGTGAACCCAGTCATAACTTACTCAACAGCAACCGAAAGAGTAAACGAGCTGGCC
ATCCGAAACAGAACACTCTCAGCTGGATATACAACAACAAGCTGCATTACACACTATAAC
AAAGGATATTGTTTTCATATAGTAGAAATAAATCATAAAAGCTTAAACACATTTCAACCC
ATGTTGTTCAAAACAGAGATTCCAAAAAGCTGCAGTTAA

# Drug_Target_3_General_Function:
Not Available

# Drug_Target_3_General_References:
2827373	van Wyke Coelingh KL, Winter CC, Murphy BR: Nucleotide and deduced amino acid sequence of hemagglutinin-neuraminidase genes of human type 3 parainfluenza viruses isolated from 1957 to 1983. Virology. 1988 Jan;162(1):137-43.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
3140

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
64331

# Drug_Target_3_Name:
Hemagglutinin-neuraminidase

# Drug_Target_3_Number_of_Residues:
572

# Drug_Target_3_PDB_ID:
1V3E

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00423	HN

# Drug_Target_3_Protein_Sequence:
>Hemagglutinin-neuraminidase
MEYWKHTNHGKDAGNELETSMATHGNKLTNKIIYILWTIILVLLSIVFIIVLINSIKSEK
AHESLLRDINNEFMEITGKIQMASDNTNDLIQSGVNTRLLTIQSHVQNYIPISLTQQMSD
LRKFISEITIRNDNQEVLPQRITHDVGIKPLNPDDFWRCTSGLPSLMKTPKIRLMPGPGL
LAMPTTDDGCIRTPSLVINDLIYAYTSNLITRGCQDIGKSYQVLQIGIITVNSDLVPDLN
PRISHTFNINDNRKSCSLALLNTDVYQLCSTPKVDERSDYASSGIEDIVLDIVNYDGSIS
TTRFKNNNISFDQPYAALYPSVGPGIYYKGKIIFLGYGGLEHPINENVICNTTGCPGKTQ
RDCNQASHSPWFSDRRMVNSIIVVDKGLNSTPKLKVWTISMRQNYWGSEGRLLLLGNKIY
IYTRSTSWHSKLQLGIIDITDYSDIRIKWTWHNVLSRPGNNECPWGHSCPDGCITGVYTD
AYPLNPTGSIVSSVILDSQKSRVNPVITYSTATERVNELAIRNRTLSAGYTTTSCITHYN
KGYCFHIVEINHKSLNTFQPMLFKTEIPKSCS

# Drug_Target_3_Reaction:
Hydrolysis of alpha-(2->3)-, alpha-(2->6)-, alpha-(2->8)- glycosidic linkages of terminal sialic acid residues in oligosaccharides, glycoproteins, glycolipids, colominic acid and synthetic substrates ALL_REAC (other) R03491 R04018 R04634 R04650 R05115 R05117 R05996(G) R05998(G) R05999(G) R06012(G) R06147(G) R06253(G) INHIBITOR 2-Deoxy-2,3-dehydro-N-acetylneuraminic acid

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Neuraminidase activity ensures the efficient spread of the virus by dissociating the mature virions from the neuraminic acid containing glycoproteins

# Drug_Target_3_SwissProt_ID:
P12564

# Drug_Target_3_SwissProt_Name:
HN_PI3HV

# Drug_Target_3_Synonyms:
EC 3.2.1.18

# Drug_Target_3_Theoretical_pI:
7.96

# Drug_Target_3_Transmembrane_Regions:
32-52

# Drug_Target_4_Cellular_Location:
Cytoplasmic

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
X04436

# Drug_Target_4_GenBank_ID_Protein:
40770

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
tetX

# Drug_Target_4_Gene_Sequence:
>3948 bp
ATGCCAATAACCATAAATAATTTTAGATATAGTGATCCTGTTAATAATGATACAATTATT
ATGATGGAGCCACCATACTGTAAGGGTCTAGATATCTATTATAAGGCTTTCAAAATAACA
GATCGTATTTGGATAGTGCCGGAAAGGTATGAATTTGGGACAAAACCTGAAGATTTTAAC
CCACCATCTTCATTAATAGAAGGTGCATCTGAGTATTACGATCCAAATTATTTAAGGACT
GATTCTGATAAAGATAGATTTTTACAAACCATGGTAAAACTGTTTAACAGAATTAAAAAC
AATGTAGCAGGTGAAGCCTTATTAGATAAGATAATAAATGCCATACCTTACCTTGGAAAT
TCATATTCCTTACTAGACAAGTTTGATACAAACTCTAATTCAGTATCTTTTAATTTATTA
GAACAAGACCCCAGTGGAGCAACTACAAAATCAGCAATGCTGACAAATTTAATAATATTT
GGACCTGGGCCTGTTTTAAATAAAAATGAGGTTAGAGGTATTGTATTGAGGGTAGATAAT
AAAAATTACTTCCCATGTAGAGATGGTTTTGGCTCAATAATGCAAATGGCATTTTGCCCA
GAATATGTACCTACCTTTGATAATGTAATAGAAAATATTACGTCACTCACTATTGGCAAA
AGCAAATATTTTCAAGATCCAGCATTACTATTAATGCACGAACTTATACATGTACTACAT
GGTTTATACGGAATGCAGGTATCAAGCCATGAAATTATTCCATCCAAACAAGAAATTTAT
ATGCAGCATACATATCCAATAAGTGCTGAAGAACTATTCACTTTTGGCGGACAGGATGCT
AATCTTATAAGTATTGATATAAAAAACGATTTATATGAAAAAACTTTAAATGATTATAAA
GCTATAGCTAACAAACTTAGTCAAGTCACTAGCTGCAATGATCCCAACATTGATATTGAT
AGCTACAAACAAATATATCAACAAAAATATCAATTCGATAAAGATAGCAATGGACAATAT
ATTGTAAATGAGGATAAATTTCAGATACTATATAATAGCATAATGTATGGTTTTACAGAG
ATTGAATTGGGAAAAAAATTTAATATAAAAACTAGACTTTCTTATTTTAGTATGAATCAT
GACCCTGTAAAAATTCCAAATTTATTAGATGATACAATTTACAATGATACAGAAGGATTT
AATATAGAAAGCAAAGATCTGAAATCTGAATATAAAGGACAAAATATGAGGGTAAATACA
AATGCTTTTAGAAATGTTGATGGATCAGGCCTAGTTTCAAAACTTATTGGCTTATGTAAA
AAAATTATACCACCAACAAATATAAGAGAAAATTTATATAATAGAACTGCATCATTAACA
GATTTAGGAGGAGAATTATGTATAAAAATTAAAAATGAAGATTTAACTTTTATAGCTGAA
AAAAATAGCTTTTCAGAAGAACCATTTCAAGATGAAATAGTTAGTTATAATACAAAAAAT
AAACCATTAAATTTTAATTATTCGCTAGATAAAATTATTGTAGATTATAATCTACAAAGT
AAAATTACATTACCTAATGATAGGACAACCCCAGTTACAAAAGGAATTCCATATGCTCCA
GAATATAAAAGTAATGCTGCAAGTACAATAGAAATACATAATATTGATGACAATACAATA
TATCAATATTTGTATGCTCAAAAATCTCCTACAACTCTACAAAGAATAACTATGACTAAT
TCTGTTGATGACGCATTAATAAATTCCACCAAAATATATTCATATTTTCCATCTGTAATC
AGTAAAGTTAACCAAGGTGCACAAGGAATTTTATTCTTACAGTGGGTGAGAGATATAATT
GATGATTTTACCAATGAATCTTCACAAAAAACTACTATTGATAAAATTTCAGATGTATCC
ACTATTGTTCCTTATATAGGACCCGCATTAAACATTGTAAAACAAGGCTATGAGGGAAAC
TTTATAGGCGCTTTAGAAACTACCGGAGTGGTTTTATTATTAGAATATATTCCAGAAATT
ACTTTACCAGTAATTGCAGCTTTATCTATAGCAGAAAGTAGCACACAAAAAGAAAAGATA
ATAAAAACAATAGATAACTTTTTAGAAAAAAGATATGAAAAATGGATTGAAGTATATAAA
CTAGTAAAAGCAAAATGGTTAGGCACAGTTAATACGCAATTCCAAAAAAGAAGTTATCAA
ATGTATAGATCTTTAGAATATCAAGTAGATGCAATAAAAAAAATAATAGACTATGAATAT
AAAATATATTCAGGACCTGATAAGGAACAAATTGCCGACGAAATTAATAATCTGAAAAAC
AAACTTGAAGAAAAGGCTAATAAAGCAATGATAAACATAAATATATTTATGAGGGAAAGT
TCTAGATCATTTTTAGTTAATCAAATGATTAACGAAGCTAAAAAGCAGTTATTAGAGTTT
GATACTCAAAGCAAAAATATTTTAATGCAGTATATAAAAGCAAATTCTAAATTTATAGGT
ATAACTGAACTAAAAAAATTAGAATCAAAAATAAACAAAGTTTTTTCAACACCAATTCCA
TTTTCTTATTCTAAAAATCTGGATTGTTGGGTTGATAATGAAGAAGATATAGATGTTATA
TTAAAAAAGAGTACAATTTTAAATTTAGATATTAATAATGATATTATATCAGATATATCT
GGGTTTAATTCATCTGTAATAACATATCCAGATGCTCAATTGGTGCCCGGAATAAATGGC
AAAGCAATACATTTAGTAAACAATGAATCTTCTGAAGTTATAGTGCATAAAGCTATGGAT
ATTGAATATAATGATATGTTTAATAATTTTACCGTTAGCTTTTGGTTGAGGGTTCCTAAA
GTATCTGCTAGTCATTTAGAACAATATGGCACAAATGAGTATTCAATAATTAGCTCTATG
AAAAAACATAGTCTATCAATAGGATCTGGTTGGAGTGTATCACTTAAAGGTAATAACTTA
ATATGGACTTTAAAAGATTCCGCGGGAGAAGTTAGACAAATAACTTTTAGGGATTTACCT
GATAAATTTAATGCTTATTTAGCAAATAAATGGGTTTTTATAACTATTACTAATGATAGA
TTATCTTCTGCTAATTTGTATATAAATGGAGTACTTATGGGAAGTGCAGAAATTACTGGT
TTAGGAGCTATTAGAGAGGATAATAATATAACATTAAAACTAGATAGATGTAATAATAAT
AATCAATACGTTTCTATTGATAAATTTAGGATATTTTGCAAAGCATTAAATCCAAAAGAG
ATTGAAAAATTATACACAAGTTATTTATCTATAACCTTTTTAAGAGACTTCTGGGGAAAC
CCTTTACGATATGATACAGAATATTATTTAATACCAGTAGCTTCTAGTTCTAAAGATGTT
CAATTGAAAAATATAACAGATTATATGTATTTGACAAATGCGCCATCGTATACTAACGGA
AAATTGAATATATATTATAGAAGGTTATATAATGGACTAAAATTTATTATAAAAAGATAT
ACACCTAATAATGAAATAGATTCTTTTGTTAAATCAGGTGATTTTATTAAATTATATGTA
TCATATAACAATAATGAGCACATTGTAGGTTATCCGAAAGATGGAAATGCCTTTAATAAT
CTTGATAGAATTCTAAGAGTAGGTTATAATGCCCCAGGTATCCCTCTTTATAAAAAAATG
GAAGCAGTAAAATTGCGTGATTTAAAAACCTATTCTGTACAACTTAAATTATATGATGAT
AAAAATGCATCTTTAGGACTAGTAGGTACCCATAATGGTCAAATAGGCAACGATCCAAAT
AGGGATATATTAATTGCAAGCAACTGGTACTTTAATCATTTAAAAGATAAAATTTTAGGA
TGTGATTGGTACTTTGTACCTACAGATGAAGGATGGACAAATGATTAA

# Drug_Target_4_General_Function:
Involved in metalloendopeptidase activity

# Drug_Target_4_General_References:
12552129	Bruggemann H, Baumer S, Fricke WF, Wiezer A, Liesegang H, Decker I, Herzberg C, Martinez-Arias R, Merkl R, Henne A, Gottschalk G: The genome sequence of Clostridium tetani, the causative agent of tetanus disease. Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1316-21. Epub 2003 Jan 27.
1331807	Schiavo G, Benfenati F, Poulain B, Rossetto O, Polverino de Laureto P, DasGupta BR, Montecucco C: Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature. 1992 Oct 29;359(6398):832-5.
1396558	Schiavo G, Poulain B, Rossetto O, Benfenati F, Tauc L, Montecucco C: Tetanus toxin is a zinc protein and its inhibition of neurotransmitter release and protease activity depend on zinc. EMBO J. 1992 Oct;11(10):3577-83.
1935979	Krieglstein KG, Henschen AH, Weller U, Habermann E: Limited proteolysis of tetanus toxin. Relation to activity and identification of cleavage sites. Eur J Biochem. 1991 Nov 15;202(1):41-51.
2108021	Krieglstein K, Henschen A, Weller U, Habermann E: Arrangement of disulfide bridges and positions of sulfhydryl groups in tetanus toxin. Eur J Biochem. 1990 Feb 22;188(1):39-45.
3510187	Fairweather NF, Lyness VA, Pickard DJ, Allen G, Thomson RO: Cloning, nucleotide sequencing, and expression of tetanus toxin fragment C in Escherichia coli. J Bacteriol. 1986 Jan;165(1):21-7.
3536478	Eisel U, Jarausch W, Goretzki K, Henschen A, Engels J, Weller U, Hudel M, Habermann E, Niemann H: Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins. EMBO J. 1986 Oct;5(10):2495-502.
3774547	Fairweather NF, Lyness VA: The complete nucleotide sequence of tetanus toxin. Nucleic Acids Res. 1986 Oct 10;14(19):7809-12.
9334741	Umland TC, Wingert LM, Swaminathan S, Furey WF, Schmidt JJ, Sax M: Structure of the receptor binding fragment HC of tetanus neurotoxin. Nat Struct Biol. 1997 Oct;4(10):788-92.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
2570

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
150684

# Drug_Target_4_Name:
Tetanus toxin

# Drug_Target_4_Number_of_Residues:
1315

# Drug_Target_4_PDB_ID:
Not Available

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF01742	Peptidase_M27
PF07951	Toxin_R_bind_C
PF07952	Toxin_trans
PF07953	Toxin_R_bind_N

# Drug_Target_4_Protein_Sequence:
>Tetanus toxin precursor
MPITINNFRYSDPVNNDTIIMMEPPYCKGLDIYYKAFKITDRIWIVPERYEFGTKPEDFN
PPSSLIEGASEYYDPNYLRTDSDKDRFLQTMVKLFNRIKNNVAGEALLDKIINAIPYLGN
SYSLLDKFDTNSNSVSFNLLEQDPSGATTKSAMLTNLIIFGPGPVLNKNEVRGIVLRVDN
KNYFPCRDGFGSIMQMAFCPEYVPTFDNVIENITSLTIGKSKYFQDPALLLMHELIHVLH
GLYGMQVSSHEIIPSKQEIYMQHTYPISAEELFTFGGQDANLISIDIKNDLYEKTLNDYK
AIANKLSQVTSCNDPNIDIDSYKQIYQQKYQFDKDSNGQYIVNEDKFQILYNSIMYGFTE
IELGKKFNIKTRLSYFSMNHDPVKIPNLLDDTIYNDTEGFNIESKDLKSEYKGQNMRVNT
NAFRNVDGSGLVSKLIGLCKKIIPPTNIRENLYNRTASLTDLGGELCIKIKNEDLTFIAE
KNSFSEEPFQDEIVSYNTKNKPLNFNYSLDKIIVDYNLQSKITLPNDRTTPVTKGIPYAP
EYKSNAASTIEIHNIDDNTIYQYLYAQKSPTTLQRITMTNSVDDALINSTKIYSYFPSVI
SKVNQGAQGILFLQWVRDIIDDFTNESSQKTTIDKISDVSTIVPYIGPALNIVKQGYEGN
FIGALETTGVVLLLEYIPEITLPVIAALSIAESSTQKEKIIKTIDNFLEKRYEKWIEVYK
LVKAKWLGTVNTQFQKRSYQMYRSLEYQVDAIKKIIDYEYKIYSGPDKEQIADEINNLKN
KLEEKANKAMININIFMRESSRSFLVNQMINEAKKQLLEFDTQSKNILMQYIKANSKFIG
ITELKKLESKINKVFSTPIPFSYSKNLDCWVDNEEDIDVILKKSTILNLDINNDIISDIS
GFNSSVITYPDAQLVPGINGKAIHLVNNESSEVIVHKAMDIEYNDMFNNFTVSFWLRVPK
VSASHLEQYGTNEYSIISSMKKHSLSIGSGWSVSLKGNNLIWTLKDSAGEVRQITFRDLP
DKFNAYLANKWVFITITNDRLSSANLYINGVLMGSAEITGLGAIREDNNITLKLDRCNNN
NQYVSIDKFRIFCKALNPKEIEKLYTSYLSITFLRDFWGNPLRYDTEYYLIPVASSSKDV
QLKNITDYMYLTNAPSYTNGKLNIYYRRLYNGLKFIIKRYTPNNEIDSFVKSGDFIKLYV
SYNNNEHIVGYPKDGNAFNNLDRILRVGYNAPGIPLYKKMEAVKLRDLKTYSVQLKLYDD
KNASLGLVGTHNGQIGNDPNRDILIASNWYFNHLKDKILGCDWYFVPTDEGWTND

# Drug_Target_4_Reaction:
Hydrolysis of -Gln76!Phe- bond in synaptobrevin (also known as neuronal vesicle-associated membrane protein, VAMP)

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Tetanus toxin acts by inhibiting neurotransmitter release. It binds to peripheral neuronal synapses, is internalized and moves by retrograde transport up the axon into the spinal cord where it can move between postsynaptic and presynaptic neurons. It inhibits neurotransmitter release by acting as a zinc endopeptidase that catalyzes the hydrolysis of the '76-Gln-|-Phe- 77' bond of synaptobrevin-2

# Drug_Target_4_SwissProt_ID:
P04958

# Drug_Target_4_SwissProt_Name:
TETX_CLOTE

# Drug_Target_4_Synonyms:
EC 3.4.24.68
Tentoxylysin
Tetanus toxin precursor

# Drug_Target_4_Theoretical_pI:
5.91

# Drug_Target_4_Transmembrane_Regions:
None

#END_DRUGCARD DB04265
